[1] 陈荣花, 张瑞荣, 王希柱, 等. 25羟维生素D、NT-proBNP与左心室肥厚的相关性研究[J]. 医学临床研究, 2015, 32(11):2188-2190. [2] 张瑞荣, 陈荣花, 王希柱, 等. 不同原因所致心室肥厚患者血清维生素D水平差异分析[J]. 医学临床研究, 2016, 33(1):143-144. [3] Vacek JL, Vanga SR, Good M, et al. Vitamin D deficiency and supplementation and relation to cardiovascular health [J]. Am J Cardiol, 2012, 109(3):359-363. [4] Watts NB, Lewiecki EM, Miller PD, et al. National osteoporosis foundation 2008 clinician’s guide to prevention and treatment of osteoporosis and the world health organization fracture risk assessment tool(FRAX):what they mean to the bone densitometrist and bone technologist [J]. J Clin Densitom, 2008, 11(4):473-477. [5] Lu L, Yu Z, Pan A, et al. Plasma 25-hydroxyvitamin D concentration and metabolic syndrome among middle-aged and elderly Chinese individuals [J]. Diabetes Care, 2009, 32(7):1278-1283. [6] Jorde R, Grimnes G. Vitamin D and metabolic health with special reference to the effect of vitamin D on serum lipids [J]. Prog Lipid Res, 2011, 50(4):303-312. [7] Richart T, Thijs L, Nawrot T, et al. The metabolic syndrome and carotid intima-media thickness in relation to the parathyroid hormone to 25-OH-D(3) ratio in a general population [J]. Am J Hypertens, 2011, 24(1):102-109. [8] Sun X, Cao ZB, Tanisawa K, et al. Associations between the serum 25(OH)D concentration and lipid profiles in Japanese men [J]. J Atheroseler Thromb, 2015, 22(4):355-362. [9] Lupton JR, Faridi KF, Martin SS, et al. Deficient serum 25-hydrnxyvitamin D is associated with an atherogenic lipid profile: The Very Large Database of Lipids(VLDL-3) study [J]. J Clin Lipidol, 2016, 10(1):72-81. [10] Zhang MC, Li HX, Liu HM, et al. Serum vitamin D is low and inversely associated with LDL cholesterol in the Kazak ethnic population: a cross-sectional study[J]. Med Sci Monit, 2014, 20: 1274-1283. [11] Oh J, Weng S, Felton SK, et al. 1-25(OH)2 vitamin D inhibits foam cell formation and suppresses macrophage cholesterol uptake in patients with type 2 diabetes mellitus [J]. Circulation, 2009, 120(8):687-698.
2017, Vol. 34 
